GIST research hub

A Study of Ripretinib vs Sunitinib in Patients With Advanced GIST With Specific KIT Exon Mutations Who Were Previously Treated With Imatinib

This study is testing a new medicine called ripretinib against an existing one, sunitinib, for people with advanced GIST. It's for those whose GIST has specific gene changes and has progressed after earlier treatment with imatinib.